Home › Funds › D. E. Shaw & Co › CVM
D. E. Shaw & Co position in CVM
CEL-SCI CORP · Health Care
Latest position (Q2 2024)53.22K sh
Reported value held$61.73K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 492.09K | $5.41M | New |
| Q4 2021 | 625.43K | $4.44M | Add |
| Q1 2022 | 666.49K | $2.62M | Add |
| Q1 2023 | 33.22K | $77.06K | New |
| Q2 2023 | 52.29K | $126.01K | Add |
| Q3 2023 | 35.53K | $44.41K | Reduce |
| Q4 2023 | 105.57K | $287.16K | Add |
| Q1 2024 | 188.54K | $360.12K | Add |
| Q2 2024 | 53.22K | $61.73K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CVM
- Vanguard Group 285.12K sh · $1.50M · Q4 2025
- Renaissance Technologies 572.46K sh · $595.36K · Q2 2026
- Citadel Advisors 198.50K sh · $206.44K · Q2 2026
- Geode Capital Management 88.20K sh · $91.78K · Q2 2026
- BlackRock Inc 43.26K sh · $44.99K · Q2 2026
- Bank of America Corp 40.92K sh · $42.55K · Q2 2026
- Northern Trust Corp 21.08K sh · $21.93K · Q2 2026
- UBS Group AG 8.03K sh · $8.35K · Q2 2026
- Morgan Stanley 41 sh · $43 · Q2 2026
- JPMorgan Chase & Co 7 sh · $8 · Q2 2026